MAGELLAN HEALTH,INC. (NASDAQ:MGLN) Files An 8-K Results of Operations and Financial ConditionItem 2.02. Results of Operations and Financial Condition
On December 7, 2018, Magellan Health, Inc. (the “Company”) issued a press release with respect to its 2019 earnings guidance. Attached and incorporated herein by reference as Exhibit 99.1 is a copy of the press release dated December 7, 2018.
Item 9.01. Financial Statements, Pro Forma Financial Information and Exhibits
(a) Financial Statements of business acquired: Not applicable.
(b) Pro forma financial information: Not applicable.
(d) Exhibits:See Exhibit Index.
MAGELLAN HEALTH INC ExhibitEX-99.1 2 ex-99d1.htm EX-99.1 mgln_Ex99_1 Exhibit 99.1 NEWS RELEASE Media Contact: Lilly Ackley,…To view the full exhibit click
About MAGELLAN HEALTH,INC. (NASDAQ:MGLN)
Magellan Health, Inc. is engaged in the healthcare management business. The Company’s segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC). Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists primarily of operational support functions. It provides services to health plans and other managed care organizations (MCOs).
An ad to help with our costs